about
Dengue virus inhibits alpha interferon signaling by reducing STAT2 expressionSelection for virulent dengue viruses occurs in humans and mosquitoesThe global distribution of yellow fever and dengueStereophysicochemical variability plots highlight conserved antigenic areas in FlavivirusesDengue viruses - an overviewNation-wide, web-based, geographic information system for the integrated surveillance and control of dengue fever in MexicoDengue Fever in Humanized NOD/SCID MiceRecent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and PathogenesisLarge-scale analysis of antigenic diversity of T-cell epitopes in dengue virusAn adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypesCross-Reactive T-Cell Responses to the Nonstructural Regions of Dengue Viruses among Dengue Fever and Dengue Hemorrhagic Fever Patients in MalaysiaDengue Virus Evolution and Virulence ModelsConstruction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeysEmerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue virusesExtensive structural change of the envelope protein of dengue virus induced by a tuned ionic strength: conformational and energetic analyses.A predictive model for Dengue Hemorrhagic Fever epidemics.Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model.Antibody responses to Asian and American genotypes of dengue 2 virus in immunized miceAntiviral actions of flavanoid-derived compounds on dengue virus type-2Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virusAsymmetry in the presence of migration stabilizes multistrain disease outbreaks.Forecasting dengue vaccine demand in disease endemic and non-endemic countries.Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaquesMulticountry prospective clinical evaluation of two enzyme-linked immunosorbent assays and two rapid diagnostic tests for diagnosing dengue fever.Quality of life among adults with confirmed dengue in Brazil.Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2A Multi-country Study of the Household Willingness-to-Pay for Dengue Vaccines: Household Surveys in Vietnam, Thailand, and Colombia.Dengue and dengue hemorrhagic fever, Brazil, 1981-2002.Models of dengue virus infection.Dengue vaccine: priorities and progress.Assessment of optimal strategies in a two-patch dengue transmission model with seasonality.Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.Dengue Vaccine: The Current StatusDengue vaccines for travelers.The development of an early warning system for climate-sensitive disease risk with a focus on dengue epidemics in Southeast Brazil.Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.Spatial distribution and risk factors of dengue and Japanese encephalitis virus infection in urban settings: the case of Vientiane, Lao PDR.Development and evaluation of an enzyme-linked immunosorbent assay for dengue capsid.Epidemics with multistrain interactions: the interplay between cross immunity and antibody-dependent enhancement.
P2860
Q24522443-1AA40B3B-3641-49FE-B1D5-664DEA7D1726Q24558700-2E18B836-E2CB-4B0F-8395-C4220AD2DE63Q24607960-73FEB3F5-A1CE-4E58-BA6E-3718D1DA04E2Q24804265-1A04A4B4-CBAF-4A26-B4E2-309E6C6ECA92Q27026302-06D05555-91D1-484F-9120-0379FA14581EQ27310379-BCE9B9EB-6126-4F4E-803C-CDD9842F2876Q27472676-B24D07A7-2644-46B7-90BC-7E764794D40EQ27477646-2FEE6F2A-73C6-4B72-ABDD-EE53862CA209Q27477942-A107D85C-6C9B-4345-9365-8B0BE0BAF789Q27478104-FBB2CB8C-BFE6-49DB-86FC-506F6AE48E27Q27481431-C9DB21A3-C10F-4AAF-8C97-BEA89E6BBC97Q27485628-BBBDE84B-6B6A-4DDF-B0B8-61C1370F4A31Q27487946-05E6ADF0-E8E7-4905-B47F-718DA7E9B590Q27491049-13CC792E-E028-4C57-BCFA-830B1A217DABQ27860800-F70436B1-EE5E-4233-8B60-0AF4C3EF2980Q30423742-D4AAAC0C-9082-4815-8373-1977D2BD4176Q33356395-F03AD320-8FF8-413B-ACEC-6FD8C978CE0BQ33380611-ECF1A5D4-B36C-4E9B-B9FE-2CFD22B04DA1Q33859020-68D3A74C-3398-464C-A7D4-AE0FB633A84AQ33883807-0F8B7FC3-E5FA-4CAC-8CFC-F262246B6BD3Q34175884-DE8CF80C-EBD0-45A5-BC78-D915D51DFB64Q34372767-51683D76-E0AE-497F-8E60-E0B5197114B1Q34663963-5ED4822A-98F2-418E-BA63-A60AF915D97CQ35031833-3CF255D9-4E80-420A-99FC-3EB649593155Q35193142-8D859CB7-6B7B-4874-83AD-117629EE413AQ35246139-C390E4B4-8897-40F3-B083-85EDC3AB5027Q35624552-3845A7BD-526C-4BE6-98B3-580A635E5C5EQ35648537-7EB04A9B-0675-400B-A14E-AF0C28873A35Q35804366-EC69ADDF-2CDA-4C41-AD45-6D6CE360840CQ35942502-69FB5437-6AD7-4BBB-80DC-0FB679F2C1D2Q35964754-EFC38594-BC62-42D4-94C8-89B1BD6BB14FQ36310590-CE680509-969A-4CF6-955D-A9BB1630502CQ36825107-96225F0A-23D7-469C-9A7D-88E372614B33Q37039194-2212B8AD-0087-4C8B-BFC6-D10C7BA106C4Q37194772-5E5CF08A-F66C-49E3-A00A-254E761DD779Q39191302-58161EF2-C049-4FFA-86A4-3C5387BFA10CQ39468688-092146D3-DE60-4F80-A480-56F0E348A0EDQ39891330-E69FDD1B-C425-4529-9DBA-F32380067534Q40290490-CCDAD103-8C6E-4AB6-AED0-9B7E57DF29DEQ40369297-3C005856-216D-4990-90F3-70FDD7A4C546
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The future of dengue vaccines.
@ast
The future of dengue vaccines.
@en
The future of dengue vaccines.
@nl
type
label
The future of dengue vaccines.
@ast
The future of dengue vaccines.
@en
The future of dengue vaccines.
@nl
prefLabel
The future of dengue vaccines.
@ast
The future of dengue vaccines.
@en
The future of dengue vaccines.
@nl
P1433
P1476
The future of dengue vaccines.
@en
P2093
Jacqueline Deen
Scott B Halstead
P304
P356
10.1016/S0140-6736(02)11276-1
P407
P577
2002-10-01T00:00:00Z